Related Experiment Videos
Nervous control of liver metabolism and hemodynamics
A Gardemann1, G P Püschel, K Jungermann
1Institut für Biochemie, Georg-August-Universität Göttingen, Federal Republic of Germany.
European Journal of Biochemistry
|July 15, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E2 sensitivity in mice with diet-induced MASH.
Cell communication and signaling : CCS·2025
CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis.
Thrombosis research·2017
Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.
Experimental biology and medicine (Maywood, N.J.)·2017
Comparison of expression patterns and cell adhesion properties of the mouse biliary glycoproteins Bgp1 and Bgp2.
European journal of biochemistry·2020
Structure of the core oligosaccharide of a rough-type lipopolysaccharide of Pseudomonas syringae pv. phaseolicola.
European journal of biochemistry·2004
Monitoring ligand-mediated nuclear receptor-coregulator interactions by noncovalent mass spectrometry.
European journal of biochemistry·2004
Solution structure of long neurotoxin NTX-1 from the venom of Naja naja oxiana by 2D-NMR spectroscopy.
European journal of biochemistry·2004
Trans-splicing of a mutated glycosylasparaginase mRNA sequence by a group I ribozyme deficient in hydrolysis.
European journal of biochemistry·2004
13N-ammonia positron emission tomography/magnetic resonance imaging in patients with ischemia with non-obstructive coronary arteries: focus on feature tracking and T1 mapping.
Quantitative imaging in medicine and surgery·2026
Nsp1 from divergent coronaviruses has conserved endonuclease activity.
Journal of molecular biology·2026
Mitochondrial proteomic signatures of postcardiac arrest brain injury reveal potential therapeutic targets.
The Journal of pharmacology and experimental therapeutics·2026